Tags: Biotechnology
Regeneron Acquires 23andMe for $256M: A Game-Changer in Pharma Data and Customer Insights
Regeneron plans to acquire genetic testing company 23andMe for $256 million following its bankruptcy filing. This acquisition allows Regeneron to utilize 23andMe’s extensive genomic database,…
Colossal Biosciences’ Bold Quest: Reviving the Woolly Mammoth by Creating a Woolly Mouse!
Colossal Biosciences aims to resurrect the woolly mammoth by 2028, making strides in genetic engineering by creating mice with mammoth-like fur using CRISPR technology. Led…
Nucleus Genomics Secures $14M Series A Funding: The Controversial Genetics Testing Startup Revolutionizing Genomic Insights
Delian Asparouhov, a partner at Founders Fund, recently explored his genetics using Nucleus Genomics, a startup specializing in DNA testing through saliva samples. His results…
Sam Altman-Backed Retro Biosciences Secures $1 Billion to Revolutionize Human Lifespan Extension
OpenAI CEO Sam Altman is heavily investing in the biotech sector, particularly in Retro Biosciences, a startup focused on extending healthy human lifespans by 10…
Recent Post
Cetegories
Join Our Newsletter
Daily Free Our Fashion News
Straight To Your Inbox
Straight To Your Inbox
